Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Depreciation and Depletion (2016 - 2019)

Elevance Health (ELV) has disclosed Depreciation and Depletion for 10 consecutive years, with $38.0 million as the latest value for Q4 2019.

  • Quarterly Depreciation and Depletion rose 18.75% to $38.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $147.0 million through Dec 2019, up 18.55% year-over-year, with the annual reading at $94.0 million for FY2025, 10.48% down from the prior year.
  • Depreciation and Depletion for Q4 2019 was $38.0 million at Elevance Health, roughly flat from $38.0 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $38.0 million in Q3 2019, with the low at $25.1 million in Q1 2015.
  • Average Depreciation and Depletion over 5 years is $29.6 million, with a median of $27.8 million recorded in 2015.
  • The sharpest move saw Depreciation and Depletion decreased 6.67% in 2015, then grew 22.58% in 2019.
  • Over 5 years, Depreciation and Depletion stood at $27.8 million in 2015, then decreased by 5.4% to $26.3 million in 2016, then increased by 10.27% to $29.0 million in 2017, then rose by 10.34% to $32.0 million in 2018, then grew by 18.75% to $38.0 million in 2019.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $38.0 million, $38.0 million, and $37.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.